From: Resource utilization, costs and treatment patterns of switching and discontinuing treatment of MS patients with high relapse activity
Mean
Standard error
Upper level of 95% CI
Lower level of 95% CI
HRA group
$26,803.19
$1126.41
$24,478.92
$28,793.61
Non-HRA group
$14,745.85
$211.09
$14,365.36
$15,140.86
Cost difference
12,057.34
$1149.85
$9,716.94
$14,073.66